|
Michael T. McCaul
|
house |
ALBANY INTL CORP |
ALB |
STOCK |
SALE
|
Nov. 20, 2016 |
$$1,000-10,000 |
Dec. 21, 2016 |
|
Michael T. McCaul
|
house |
ALBANY INTL CORP |
ALB |
STOCK |
SALE
|
Nov. 20, 2016 |
$$1,000-10,000 |
Dec. 21, 2016 |
|
Michael T. McCaul
|
house |
ALBANY INTL CORP |
ALB |
STOCK |
SALE
|
Nov. 20, 2016 |
$$1,000-10,000 |
Dec. 21, 2016 |
|
Michael T. McCaul
|
house |
ALBANY INT CORP |
ALB |
STOCK |
Sale
|
Nov. 20, 2016 |
$$1,000-15,000 |
Dec. 21, 2016 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
PURCHASE
|
Nov. 19, 2016 |
$$50,001-100,000 |
Dec. 21, 2016 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
PURCHASE
|
Nov. 19, 2016 |
$$1,000,001-5,000,000 |
Dec. 21, 2016 |
|
Thomas R Carper
|
senate |
JPM Contingent Autocall on Halliburton Rate/Coupon: 10% Matures: 05/18/2018 |
HAL |
OPTION |
Sale (Full)
|
Nov. 18, 2016 |
$$1,001 - $15,000 |
March 14, 2017 |
|
Thomas R Carper
|
senate |
JPM Contingent Autocall on Halliburton Rate/Coupon: 10% Matures: 05/18/2018 |
HAL |
OPTION |
Sale (Full)
|
Nov. 18, 2016 |
$$1,001 - $15,000 |
Dec. 1, 2016 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
PURCHASE
|
Nov. 17, 2016 |
$$1,000-$15,000 |
Dec. 21, 2016 |
|
Michael T. McCaul
|
house |
HALiburton CO |
HAL |
STOCK |
Purchase
|
Nov. 17, 2016 |
$$50,001-$100,000 |
Dec. 21, 2016 |
|
Michael T. McCaul
|
house |
ALBANY INTL CORP |
ALB |
STOCK |
PURCHASE
|
Nov. 17, 2016 |
$$15,001-50,000 |
Dec. 21, 2016 |
|
Michael T. McCaul
|
house |
HALIBURTON. CO |
HAL |
STOCK |
Sale
|
Nov. 17, 2016 |
$$1,000,$-15,000 |
Dec. 21, 2016 |
|
Michael T. McCaul
|
house |
ALBANY INTL CORP |
ALB |
STOCK |
PURCHASE
|
Nov. 15, 2016 |
$$15,001-50,000 |
Dec. 21, 2016 |
|
Thomas R Carper
|
senate |
ALPS ETF Trust-ALPS Medical |
ALPS |
ETF |
Purchase
|
Nov. 11, 2016 |
$$1,001 - $15,000 |
Dec. 1, 2016 |
|
Thomas R Carper
|
senate |
ALPS ETF Trust-ALPS Medical |
ALPS |
ETF |
Purchase
|
Nov. 11, 2016 |
$$1,001 - $15,000 |
March 14, 2017 |
|
Richard L. Hanna
|
house |
Alnylam Pharmaceuticals, Inc. (ALNY) |
ALNY |
STOCK |
Purchase
|
Oct. 13, 2016 |
$$100,001 - $250,000 |
Nov. 27, 2016 |
|
Michael T. McCaul
|
house |
ALLERGAN PHARMACEUTICALS INC |
ALLN |
STOCK |
PURCHASE
|
Oct. 6, 2016 |
$$250,001-$500,000 |
Nov. 17, 2016 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
PURCHASE
|
Oct. 4, 2016 |
$$15,001-$50,000 |
Nov. 17, 2016 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
PURCHASE
|
Oct. 4, 2016 |
$$1,000-$15,000 |
Nov. 17, 2016 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
PURCHASE
|
Oct. 2, 2016 |
$$1,000-15,000 |
Nov. 17, 2016 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
Purchase
|
Sept. 30, 2016 |
$$15,001-$50,000 |
Oct. 14, 2016 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
Purchase
|
Sept. 29, 2016 |
$$15,001-$50,000 |
Oct. 14, 2016 |
|
Thomas MacArthur
|
house |
Astellas Pharma Inc Unsponsored ADR (ALPMY) |
ALPMY |
STOCK |
Purchase
|
Sept. 20, 2016 |
$$1,001 - $15,000 |
Nov. 7, 2016 |
|
James M Inhofe
|
senate |
Allergan plc |
ALL |
STOCK |
Purchase
|
Sept. 15, 2016 |
$$15,001 - $50,000 |
Sept. 12, 2016 |
|
James M Inhofe
|
senate |
Allergan plc |
ALL |
STOCK |
Purchase
|
Sept. 13, 2016 |
$$15,001 - $50,000 |
Oct. 20, 2016 |